The PRISME team is composed of physicists, biochemists, biologists and radiotherapists. We specialize in multidisciplinary research aimed at developing, optimizing and controlling innovative radiotherapies, whether it be hadrontherapy or therapies using radioactive ion-emitting elements or nanoparticles. These radiotherapies aim to improve the treatment of certain cancers by increasing the effect of ionizing radiation in the tumor while minimizing its harmful effects on healthy tissues.
Our multidisciplinary approach aims to quantify, understand and predict the effect of ionizing radiation on living organisms from processes induced at extremely short times (attosecond) at small scales (atomic nucleus) to long-term consequences (years) at the patient level.
We therefore design and carry out irradiation experiments on targets ranging from molecules or cells to small animals and patient samples (tumor, blood). These experiments feed an important part of our activity which consists in modeling the effects of radiation on living organisms.
One of the innovative techniques of radiotherapy is hadrontherapy, which is to send
an ion beam on the tumors to destroy them. We are working, in particular using simulations, data processing and predictions, to improve these systems by having on-line control over irradiation using dedicated detectors. These tools also have applications in imaging.
The activities can be divided into three research areas:
Axis 1 aims to develop simulations and detectors to control patient irradiation by detecting the particles emitted during hadrontherapy treatment. These developments also offer application prospects in the field of diagnostic imaging.
Axis 2 focuses on the development of multi-scale models and simulations to describe and predict the physical, chemical and biological processes induced by irradiation. It also develops irradiation and dosimetric control means for the measurement of radiobiological effects.
Axis 3 quantifies by experiment the effects induced by irradiation with molecular, cellular, multicellular, in-vitro or in-vivo systems. It focuses on the specificities of innovative radiotherapies and the personalization of care.
NON-PERMANENTS:
- DOCTORANTS / DOCTORAL STUDENTS:
- CHERCHEURS NON-PERMANENTS / NON-PERMANENT RESEARCHERS:
Warning: Undefined property: stdClass::$facet_counts in /var/www/html/wp-content/plugins/hal/wp-hal.php on line 480
Warning: Attempt to read property "facet_fields" on null in /var/www/html/wp-content/plugins/hal/wp-hal.php on line 480
- H. Almazán, L. Bernard, A. Blanchet, A. Bonhomme, C. Buck, et al.. First antineutrino energy spectrum from
U fissions with the STEREO detector at ILL. J.Phys.G, 2021, 48 (7), pp.075107. ⟨10.1088/1361-6471/abd37a⟩. ⟨hal-02973177⟩
- Peng Wang, Noam I. Libeskind, Marcel S. Pawlowski, Xi Kang, Wei Wang, et al.. The Lopsided Distribution of Satellites of Isolated Central Galaxies. The Astrophysical Journal, 2021, 914 (2), pp.78. ⟨10.3847/1538-4357/abfc4f⟩. ⟨hal-03383656⟩
- H1 Collaboration, V Andreev, A Baghdasaryan, A Baty, K Begzsuren, et al.. Measurement of charged particle multiplicity distributions in DIS at HERA and its implication to entanglement entropy of partons. European Physical Journal C: Particles and Fields, 2021, 81, pp.212. ⟨10.1140/epjc/s10052-021-08896-1⟩. ⟨hal-03054562⟩
- Peng Wang, Noam I. Libeskind, Elmo Tempel, Xi Kang, Quan Guo. Possible observational evidence for cosmic filament spin. Nature Astron., 2021, 5 (8), pp.839-845. ⟨10.1038/s41550-021-01380-6⟩. ⟨hal-03260791⟩
- Nils Krah, Denis Dauvergne, Jean Michel LĂ©tang, Simon Rit, Etienne Testa. Energy-adaptive calculation of the most likely path in proton CT. Physics in Medicine and Biology, 2021, 66, pp.20NT02. ⟨10.1088/1361-6560/ac2999⟩. ⟨hal-03353954⟩
- Nicolas MagnĂ©, Igor Latorzeff. Oligometastatic renal cell carcinoma: radiotherapy as a new standard of care?. Lancet Oncology, 2021, 22 (12), pp.1644-1645. ⟨10.1016/s1470-2045(21)00665-3⟩. ⟨hal-03507607⟩
- R. Abbott, T.D. Abbott, S. Abraham, F. Acernese, K. Ackley, et al.. Upper limits on the isotropic gravitational-wave background from Advanced LIGO and Advanced Virgo’s third observing run. Physical Review D, 2021, 104 (2), pp.022004. ⟨10.1103/PhysRevD.104.022004⟩. ⟨hal-03203682⟩
- R. Abbott, T.D. Abbott, S. Abraham, F. Acernese, K. Ackley, et al.. Search for anisotropic gravitational-wave backgrounds using data from Advanced LIGO and Advanced Virgo’s first three observing runs. Physical Review D, 2021, 104 (2), pp.022005. ⟨10.1103/PhysRevD.104.022005⟩. ⟨hal-03186190⟩
- R. Abbott, T.D. Abbott, F. Acernese, K. Ackley, C. Adams, et al.. All-sky search for long-duration gravitational-wave bursts in the third Advanced LIGO and Advanced Virgo run. Physical Review D, 2021, 104 (10), pp.102001. ⟨10.1103/PhysRevD.104.102001⟩. ⟨hal-03428826⟩
- Albert M Sirunyan, Armen Tumasyan, Wolfgang Adam, Federico Ambrogi, Thomas Bergauer, et al.. Search for the lepton flavor violating decay
3
in proton-proton collisions at
13 TeV. JHEP, 2021, 01, pp.163. ⟨10.1007/JHEP01(2021)163⟩. ⟨hal-02939897⟩